Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

sia ingen pharma - betahistino dihidrochloridas - tabletės - 16 mg; 24 mg - betahistine

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

sandoz d.d. - betahistino dihidrochloridas - tabletės - 16 mg; 8 mg; 24 mg - betahistine

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

as grindeks - memantino hidrochloridas - plėvele dengtos tabletės - 10 mg - memantine

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

orion corporation - memantino hidrochloridas - plėvele dengtos tabletės - 10 mg; 20 mg - memantine

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

accord healthcare b.v. - betahistino dihidrochloridas - tabletės - 24 mg - betahistine

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

accord healthcare s.l.u. - dasatinibas - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antinavikiniai vaistai - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

eli lilly nederland b.v. - duloksetinas - neuralgia; diabetic neuropathies; depressive disorder, major - psychoanaleptics, - duloxetine lilly yra nurodyta suaugusiems:gydant didžiosios depresijos disordertreatment cukriniu diabetu periferinis neuropatinis paintreatment, generalizuoto nerimo disorderduloxetine lilly yra nurodyta suaugusieji.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

accord healthcare s.l.u. - dasatinibas - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antinavikiniai vaistai - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ir 5. 1, jei yra duomenų apie skirtingus derinius).

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

zentiva, k.s. - duloksetinas - neuralgia; depressive disorder, major; anxiety disorders; diabetes mellitus - kiti antidepresantai - gydymo depresijos sutrikimas, diabetinis neuropatinis skausmas, nerimo sutrikimas. duloxetine zentiva yra nurodyta suaugusieji.